Felvizumab

Tax included
Felvizumab (SB 209763) is a humanized IgG1κ monoclonal antibody directed to distinct neutralizing epitopes on the F glycoprotein of RSV.
HY-P99615

Data sheet

Size
Multiple sizes
Reactivity
RSV
Application
COVID-19-anti-virus
CAS
167747-20-8